These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 36525883)
21. Newborn screening for spinal muscular atrophy: The views of affected families and adults. Boardman FK; Young PJ; Griffiths FE Am J Med Genet A; 2017 Jun; 173(6):1546-1561. PubMed ID: 28374951 [TBL] [Abstract][Full Text] [Related]
22. Spinal muscular atrophy: newborn and carrier screening. Prior TW Obstet Gynecol Clin North Am; 2010 Mar; 37(1):23-36, Table of Contents. PubMed ID: 20494255 [TBL] [Abstract][Full Text] [Related]
23. Newborn and carrier screening for spinal muscular atrophy. Prior TW; Snyder PJ; Rink BD; Pearl DK; Pyatt RE; Mihal DC; Conlan T; Schmalz B; Montgomery L; Ziegler K; Noonan C; Hashimoto S; Garner S Am J Med Genet A; 2010 Jul; 152A(7):1608-16. PubMed ID: 20578137 [TBL] [Abstract][Full Text] [Related]
24. Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study. Qian Y; McGraw S; Henne J; Jarecki J; Hobby K; Yeh WS BMC Neurol; 2015 Oct; 15():217. PubMed ID: 26499462 [TBL] [Abstract][Full Text] [Related]
25. Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go. Dangouloff T; Vrščaj E; Servais L; Osredkar D; Neuromuscul Disord; 2021 Jun; 31(6):574-582. PubMed ID: 33985857 [TBL] [Abstract][Full Text] [Related]
26. Newborn Screening for Spinal Muscular Atrophy in New York State: Clinical Outcomes From the First 3 Years. Lee BH; Deng S; Chiriboga CA; Kay DM; Irumudomon O; Laureta E; Delfiner L; Treidler SO; Anziska Y; Sakonju A; Kois C; Farooq O; Engelstad K; Laurenzano A; Hogan K; Caggana M; Saavedra-Matiz CA; Stevens CF; Ciafaloni E Neurology; 2022 Oct; 99(14):e1527-e1537. PubMed ID: 35835557 [TBL] [Abstract][Full Text] [Related]
27. Decision-making and challenges within the evolving treatment algorithm in spinal muscular atrophy: a clinical perspective. Balaji L; Farrar MA; D'Silva AM; Kariyawasam DS Expert Rev Neurother; 2023; 23(7):571-586. PubMed ID: 37227306 [TBL] [Abstract][Full Text] [Related]
28. Factors associated with delayed diagnosis of spinal muscular atrophy in China and changes in diagnostic delay. Cao Y; Cheng M; Qu Y; Bai J; Peng X; Ge X; Jin Y; Wang H; Song F Neuromuscul Disord; 2021 Jun; 31(6):519-527. PubMed ID: 33838997 [TBL] [Abstract][Full Text] [Related]
29. Newborn screening for spinal muscular atrophy: Anticipating an imminent need. Phan HC; Taylor JL; Hannon H; Howell R Semin Perinatol; 2015 Apr; 39(3):217-29. PubMed ID: 25979781 [TBL] [Abstract][Full Text] [Related]
30. Molecular diagnosis and genetic counseling for spinal muscular atrophy (SMA). Rouzier C; Chaussenot A; Paquis-Flucklinger V Arch Pediatr; 2020 Dec; 27(7S):7S9-7S14. PubMed ID: 33357600 [TBL] [Abstract][Full Text] [Related]
31. New multiplex real-time PCR approach to detect gene mutations for spinal muscular atrophy. Liu Z; Zhang P; He X; Liu S; Tang S; Zhang R; Wang X; Tan J; Peng B; Jiang L; Hong S; Zou L BMC Neurol; 2016 Aug; 16(1):141. PubMed ID: 27534852 [TBL] [Abstract][Full Text] [Related]
32. [The spectrum of spinal muscular atrophies: a population study]. Rudenskaia GE; Mamedova RA Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(8):22-5. PubMed ID: 9343477 [TBL] [Abstract][Full Text] [Related]
33. CMAP changes upon symptom onset and during treatment in spinal muscular atrophy patients: lessons learned from newborn screening. Weng WC; Hsu YK; Chang FM; Lin CY; Hwu WL; Lee WT; Lee NC; Chien YH Genet Med; 2021 Feb; 23(2):415-420. PubMed ID: 33033402 [TBL] [Abstract][Full Text] [Related]
34. Pregnancy experience in women with spinal muscular atrophy: a case series. Bencivenga RP; Zoppi D; Russo A; Cassano E; Tozza S; Iodice R; Dubbioso R; Manganelli F; Ruggiero L Acta Myol; 2023; 42(2-3):60-64. PubMed ID: 38090543 [TBL] [Abstract][Full Text] [Related]
35. Newborn screening for spinal muscular atrophy: The Wisconsin first year experience. Baker MW; Mochal ST; Dawe SJ; Wiberley-Bradford AE; Cogley MF; Zeitler BR; Piro ZD; Harmelink MM; Kwon JM Neuromuscul Disord; 2022 Feb; 32(2):135-141. PubMed ID: 35120759 [TBL] [Abstract][Full Text] [Related]
36. Recommendations for Interpreting and Reporting Silent Carrier and Disease-Modifying Variants in SMA Testing Workflows. Milligan JN; Blasco-Pérez L; Costa-Roger M; Codina-Solà M; Tizzano EF Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140824 [TBL] [Abstract][Full Text] [Related]
37. [Genetic tests and clinical re-evaluation of 85 children with suspected spinal muscular atrophy]. Ji X; Liu XQ; Shen JW; Li XH; Tao J Zhonghua Er Ke Za Zhi; 2010 Jun; 48(6):425-30. PubMed ID: 21055263 [TBL] [Abstract][Full Text] [Related]
38. Perspectives in genetic counseling for spinal muscular atrophy in the new therapeutic era: early pre-symptomatic intervention and test in minors. Serra-Juhe C; Tizzano EF Eur J Hum Genet; 2019 Dec; 27(12):1774-1782. PubMed ID: 31053787 [TBL] [Abstract][Full Text] [Related]
39. [Clinical study of 83 cases with spinal muscular atrophy in children]. Li H; Wang HL; Shan CM Zhonghua Er Ke Za Zhi; 2004 Oct; 42(10):762-4. PubMed ID: 16221347 [TBL] [Abstract][Full Text] [Related]
40. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy. Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]